Cargando…

Comment on “bevacizumab or laser for aggressive posterior retinopathy of prematurity”

Detalles Bibliográficos
Autor principal:	Samanta, Ramanuj
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2019
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6557067/ https://www.ncbi.nlm.nih.gov/pubmed/31198675 http://dx.doi.org/10.4103/tjo.tjo_139_18

Ejemplares similares

Comment on: Dramatic response to intravitreal bevacizumab in hypertensive retinopathy
por: Samanta, Ramanuj
Publicado: (2019)

Bevacizumab or laser for aggressive posterior retinopathy of prematurity
por: Blair, Michael, et al.
Publicado: (2018)

Reply to comment on: “Advantages of bevacizumab for aggressive posterior retinopathy of prematurity”
por: Schechet, Sidney A., et al.
Publicado: (2019)

Combination therapy of intravitreal ranibizumab and laser photocoagulation for aggressive posterior retinopathy of prematurity
por: Dudani, Ajay I, et al.
Publicado: (2022)

Visual acuity and electroretinography findings 3 ½ years after the first intravitreal injection of bevacizumab (Avastin) in aggressive posterior retinopathy of prematurity
por: Shah, Parag K, et al.
Publicado: (2011)

Early Experience with Intravitreal Bevacizumab Combined with Laser Treatment for Retinopathy of Prematurity
por: Raizada, Seemant, et al.
Publicado: (2011)

Favorable outcomes of adequate laser photocoagulation and salvage bevacizumab treatment for aggressive posterior retinopathy of prematurity
por: Fukushima, Yoko, et al.
Publicado: (2018)

Aggressive Posterior Retinopathy of Prematurity: Long-Term Outcomes Following Intravitreal Bevacizumab
por: Naravane, Ameay V., et al.
Publicado: (2022)

Comment on: Dramatic response to intravitreal bevacizumab in hypertensive retinopathy
por: Tripathy, Koushik, et al.
Publicado: (2019)

Regression Rates Following the Treatment of Aggressive Posterior Retinopathy of Prematurity with Bevacizumab Versus Laser: 8-Year Retrospective Analysis
por: Nicoară, Simona D., et al.
Publicado: (2016)

Response to comment on: Dramatic response to intravitreal bevacizumab in hypertensive retinopathy
por: Padhi, Srikant, et al.
Publicado: (2019)

Response to comment on: Dramatic response to intravitreal Bevacizumab in hypertensive retinopathy
por: Padhi, Srikant, et al.
Publicado: (2019)

Posterior Pole Sparing Laser Photocoagulation Combined with Intravitreal Bevacizumab Injection in Posterior Retinopathy of Prematurity
por: Kim, Rebecca, et al.
Publicado: (2014)

Combination of Intravitreal Ranibizumab and Laser Photocoagulation for Aggressive Posterior Retinopathy of Prematurity
por: Mota, Ágata, et al.
Publicado: (2012)

Aggressive Posterior Retinopathy of Prematurity (APROP): LASER as the Primary Modality of Treatment
por: Narnaware, Shilpi H, et al.
Publicado: (2021)

Response to comments on: Smartphone-based fundus documentation in retinopathy of prematurity
por: Goyal, Anubhav, et al.
Publicado: (2019)

Comment on “Impact of expansion of telemedicine screening for retinopathy of prematurity in India”
por: Agarwal, T Lalit, et al.
Publicado: (2018)

Macular Development in Aggressive Posterior Retinopathy of Prematurity
por: Pandya, Hemang K., et al.
Publicado: (2015)

Intravitreal Ranibizumab for Aggressive Posterior Retinopathy of Prematurity
por: Li, Xiu-Juan, et al.
Publicado: (2016)

Aggressive Posterior Retinopathy of Prematurity in a Premature Male Infant
por: Zhou, Jun, et al.
Publicado: (2017)

Response to comment on “Impact of expansion of telemedicine screening for retinopathy of prematurity in India”
por: Vinekar, Anand, et al.
Publicado: (2018)

Outcomes and Prognostic Factors of Intravitreal Bevacizumab Monotherapy in Zone I Stage 3+ and Aggressive Posterior Retinopathy of Prematurity
por: Nicoară, Simona Delia, et al.
Publicado: (2015)

Refractive and ocular biometric profile of children with a history of laser treatment for retinopathy of prematurity
por: Kaur, Savleen, et al.
Publicado: (2017)

Outcomes of early versus deferred laser after intravitreal ranibizumab in aggressive posterior retinopathy of prematurity
por: Gangwe, Anil Babanrao, et al.
Publicado: (2021)

Ten-year outcomes after initial management with laser photocoagulation versus intravitreal bevacizumab injection in a pair of identical twins with aggressive posterior retinopathy of prematurity
por: Jeon, Seung Hee, et al.
Publicado: (2021)

Post-Ranibizumab injection endophthalmitis in aggressive posterior retinopathy of prematurity
por: Chandra, Parijat, et al.
Publicado: (2019)

Up close with the vascular loops in aggressive posterior retinopathy of prematurity
por: Raju, Biju, et al.
Publicado: (2019)

Comprehensive Retinal Image Analysis for Aggressive Posterior Retinopathy of Prematurity
por: Rajashekar, Deepthi, et al.
Publicado: (2016)

Clinical Characteristics of Preterm Neonates with Aggressive Posterior Retinopathy of Prematurity
por: Abdel Salam Gomaa, Nancy, et al.
Publicado: (2021)

Early Experience with Intravitreal Bevacizumab Combined with Laser Treatment for Retinopathy of Prematurity
por: Ahmed, Ayesha E., et al.
Publicado: (2010)

Successful treatment of aggressive posterior retinopathy of prematurity with diode laser in ocular albinism: A case report
por: Gangwe, Anil B, et al.
Publicado: (2019)

Transpupillary Diode Laser Retinal Photocoagulation for the Treatment of Retinopathy of Prematurity: Experience in Southern Iran
por: Afarid, Mehrdad, et al.
Publicado: (2016)

Treatment of acute retinopathy of prematurity
por: Ursekar, Atul T
Publicado: (2011)

Aggressive posterior retinopathy of prematurity in infants ≥1500 g birth weight
por: Sanghi, Gaurav, et al.
Publicado: (2014)

Comment: Analysis of prenatal and postnatal risk factors of retinopathy of prematurity in a tertiary care hospital in South India
por: Krishnan, Tandava, et al.
Publicado: (2014)

Comment on: Variation in the vitreoretinal configuration of Stage 4 retinopathy of prematurity in photocoagulated and treatment-naive eyes undergoing vitrectomy
por: Sanghi, Gaurav, et al.
Publicado: (2018)

Long term refractive and structural outcome following laser treatment for zone 1 aggressive posterior retinopathy of prematurity
por: Shah, Parag K., et al.
Publicado: (2014)

Intravitreal bevacizumab (Avastin) for the treatment of proliferative sickle retinopathy
por: Shaikh, Saad
Publicado: (2008)

Comment on: Evaluation of clinical profile and screening guidelines of retinopathy of prematurity in an urban level III neonatal intensive care unit
por: Gangwe, Anil Babanrao, et al.
Publicado: (2023)

Letter to the Editor re: “Lipemia Retinalis Diagnosed Incidentally After Laser Photocoagulation Treatment for Retinopathy of Prematurity”
por: Al-Mendalawi, Mahmood Dhahir
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_tliisgj745l3iamkr5e0st1sh4